Regeneron high-dose Eylea gains FDA approval (NASDAQ:REGN)
Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The ...
Friday, November 8, 2024
Tag: Eylea
US FDA declines to approve Regeneron’s higher-dose Eylea, shares tumble By Reuters
© Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in ...
Regeneron Stock Sinks on Disappointing Sales of Eylea Treatment
Regeneron Pharmaceuticals stock was tumbling after the medicine maker reported lower sales of its Eylea treatment than Wall Street was ...
FDMT stock spikes as wet AMD therapy cuts Eylea burden (NASDAQ:FDMT)
Shidlovski Clinical-stage biotech 4D Molecular (NASDAQ:FDMT) gained on Monday after the company announced data indicating that its gene therapy candidate ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.